The constitutive androstane receptor (CAR) is a nuclear receptor involved mainly in xenobiotic and endobiotic metabolism regulation. CAR is activated directly by its ligands via the ligand binding domain (LBD) or indirectly by inhibition of the epidermal growth factor (EGF) signaling. We found that leflunomide (LEF) and its main metabolite teriflunomide (TER), both used for autoimmune diseases treatment, induce the prototype CAR target gene CYP2B6 in primary human hepatocytes. As TER was discovered to be an EGF receptor antagonist, we sought to determine if TER is an indirect activator of CAR. In primary human hepatocytes and in differentiated HepaRG cells, we found that LEF and TER up-regulate CAR target genes CYP2B6 and CYP3A4 mRNAs and enzymatic activities. TER stimulated CAR+A mutant translocation into the nucleus but neither LEF nor TER activated the CAR LBD, CAR3 variant or pregnane X receptor (PXR) in gene reporter assays. Interestingly, TER significantly up-regulated CAR mRNA expression, a result which could be a consequence of both EGF receptor and ELK-1 transcription factor inhibition by TER or by TER-mediated activation of glucocorticoid receptor (GR), an upstream hormonal regulator of CAR. We can conclude that TER is a novel indirect CAR activator which through EGF inhibition and GR activation controls both detoxification and some intermediary metabolism genes.

Department of Pharmaceutical Technology Faculty of Pharmacy Charles University Prague Czechia

Department of Pharmacology and Toxicology Faculty of Pharmacy Charles University Prague Czechia

Department of Social and Clinical Pharmacy Faculty of Pharmacy Charles University Prague Czechia

Division of Rheumatology 2nd Department of Internal Medicine Gastroenterology Faculty of Medicine University Hospital in Hradec Kralove Charles University Prague Czechia

Faculty of Medicine and Dentistry Institute of Molecular and Translational Medicine Palacky University Olomouc Czechia

Zobrazit více v PubMed

Baes M., Gulick T., Choi H. S., Martinoli M. G., Simha D., Moore D. D. (1994). A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. PubMed DOI PMC

Carazo A., Pavek P. (2015). The use of the LanthaScreen TR-FRET CAR Coactivator assay in the characterization of Constitutive Androstane Receptor (CAR) inverse agonists. PubMed DOI PMC

Carazo Fernandez A., Smutny T., Hyrsova L., Berka K., Pavek P. (2015). Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR). PubMed DOI

Chai S. C., Cherian M. T., Wang Y. M., Chen T. (2016). Small-molecule modulators of PXR and CAR. PubMed DOI PMC

Chen T., Tompkins L. M., Li L., Li H., Kim G., Zheng Y., et al. (2010). A single amino acid controls the functional switch of human constitutive androstane receptor (CAR) 1 to the xenobiotic-sensitive splicing variant CAR3. PubMed DOI PMC

de Boussac H., Gondeau C., Briolotti P., Duret C., Treindl F., Romer M., et al. (2018). Epidermal growth factor represses constitutive androstane receptor expression in primary human hepatocytes and favors regulation by pregnane X receptor. PubMed DOI

di Masi A., De Marinis E., Ascenzi P., Marino M. (2009). Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects. PubMed DOI

Dong B., Saha P. K., Huang W., Chen W., Abu-Elheiga L. A., Wakil S. J., et al. (2009). Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. PubMed DOI PMC

Dusek J., Carazo A., Trejtnar F., Hyrsova L., Holas O., Smutny T., et al. (2017). Steviol, an aglycone of steviol glycoside sweeteners, interacts with the pregnane X (PXR) and aryl hydrocarbon (AHR) receptors in detoxification regulation. PubMed DOI

Faucette S. R., Zhang T. C., Moore R., Sueyoshi T., Omiecinski C. J., LeCluyse E. L., et al. (2007). Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. PubMed DOI PMC

Gao J., He J., Zhai Y., Wada T., Xie W. (2009). The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. PubMed DOI PMC

Gao J., Yan J., Xu M., Ren S., Xie W. (2015). CAR suppresses hepatic gluconeogenesis by facilitating the ubiquitination and degradation of PGC1alpha. PubMed DOI PMC

Ghosh S., Narla R. K., Zheng Y., Liu X. P., Jun X., Mao C., et al. (1999). Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents. PubMed

Ghosh S., Zheng Y., Jun X., Narla R. K., Mahajan S., Navara C., et al. (1998). Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells. PubMed

Hardesty J. E., Al-Eryani L., Wahlang B., Falkner K. C., Shi H., Jin J., et al. (2018). Epidermal growth factor receptor signaling disruption by endocrine and metabolic disrupting chemicals. PubMed DOI PMC

Hardesty J. E., Wahlang B., Falkner K. C., Clair H. B., Clark B. J., Ceresa B. P., et al. (2017). Polychlorinated biphenyls disrupt hepatic epidermal growth factor receptor signaling. PubMed DOI PMC

Honkakoski P., Zelko I., Sueyoshi T., Negishi M. (1998). The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. PubMed DOI PMC

Hyrsova L., Smutny T., Carazo A., Moravcik S., Mandikova J., Trejtnar F., et al. (2016). The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for (“squelching”) SRC-1 coactivator. PubMed DOI PMC

Kanno Y., Suzuki M., Miyazaki Y., Matsuzaki M., Nakahama T., Kurose K., et al. (2007). Difference in nucleocytoplasmic shuttling sequences of rat and human constitutive active/androstane receptor. PubMed DOI

Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., Negishi M. (1999). Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. PubMed DOI PMC

Keen H. I., Conaghan P. G., Tett S. E. (2013). Safety evaluation of leflunomide in rheumatoid arthritis. PubMed DOI

Krausova L., Stejskalova L., Wang H., Vrzal R., Dvorak Z., Mani S., et al. (2011). Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene. PubMed DOI PMC

Li D., Mackowiak B., Brayman T. G., Mitchell M., Zhang L., Huang S. M., et al. (2015). Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells. PubMed DOI PMC

Li H., Chen T., Cottrell J., Wang H. (2009). Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes. PubMed DOI PMC

Li L., Sinz M. W., Zimmermann K., Wang H. (2012). An insulin-like growth factor 1 receptor inhibitor induces CYP3A4 expression through a pregnane X receptor-independent, noncanonical constitutive androstane receptor-related mechanism. PubMed DOI PMC

Lynch C., Pan Y., Li L., Ferguson S. S., Xia M., Swaan P. W., et al. (2013). Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches. PubMed DOI PMC

Mackowiak B., Wang H. (2016). Mechanisms of xenobiotic receptor activation: direct vs. indirect. PubMed DOI PMC

Miao J., Fang S., Bae Y., Kemper J. K. (2006). Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. PubMed DOI

Molnar F., Kublbeck J., Jyrkkarinne J., Prantner V., Honkakoski P. (2013). An update on the constitutive androstane receptor (CAR). PubMed DOI

Moore L. B., Parks D. J., Jones S. A., Bledsoe R. K., Consler T. G., Stimmel J. B., et al. (2000). Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. PubMed DOI

Mutoh S., Osabe M., Inoue K., Moore R., Pedersen L., Perera L., et al. (2009). Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). PubMed DOI PMC

Mutoh S., Sobhany M., Moore R., Perera L., Pedersen L., Sueyoshi T., et al. (2013). Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. PubMed DOI PMC

Oh K. J., Han H. S., Kim M. J., Koo S. H. (2013). CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis. PubMed DOI PMC

Osabe M., Negishi M. (2011). Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm. PubMed DOI PMC

Pascussi J. M., Gerbal-Chaloin S., Fabre J. M., Maurel P., Vilarem M. J. (2000). Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. PubMed DOI

Rezen T., Tamasi V., Lovgren-Sandblom A., Bjorkhem I., Meyer U. A., Rozman D. (2009). Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers. PubMed DOI PMC

Rojas M., Yao S., Lin Y. Z. (1996). Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. PubMed DOI

Rulcova A., Prokopova I., Krausova L., Bitman M., Vrzal R., Dvorak Z., et al. (2010). Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes. PubMed DOI

Sapio L., Gallo M., Illiano M., Chiosi E., Naviglio D., Spina A., et al. (2017). The natural cAMP elevating compound forskolin in cancer therapy: is it time? PubMed DOI

Shizu R., Osabe M., Perera L., Moore R., Sueyoshi T., Negishi M. (2017). Phosphorylated nuclear receptor CAR forms a homodimer to repress its constitutive activity for ligand activation. PubMed DOI PMC

Tolson A. H., Li H., Eddington N. D., Wang H. (2009). Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor. PubMed DOI PMC

Tzameli I., Pissios P., Schuetz E. G., Moore D. D. (2000). The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. PubMed DOI PMC

Wang H., Faucette S., Moore R., Sueyoshi T., Negishi M., LeCluyse E. (2004). Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin. PubMed DOI

Yan J., Chen B., Lu J., Xie W. (2015). Deciphering the roles of the constitutive androstane receptor in energy metabolism. PubMed DOI PMC

Yarushkin A. A., Kachaylo E. M., Pustylnyak V. O. (2013). The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4alpha and FOXO1 transcriptional activity. PubMed DOI PMC

Yu L., Wang Z., Huang M., Li Y., Zeng K., Lei J., et al. (2016). Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor. PubMed DOI

The fungicide propiconazole induces hepatic steatosis and activates PXR in a mouse model of diet-induced obesity

Allosteric Antagonism of the Pregnane X Receptor (PXR): Current-State-of-the-Art and Prediction of Novel Allosteric Sites

(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells